Decision Nº M/04/020 from Competition and Consumer Protection Commission, 2004-07-15

CourtCompetition and Consumer Protection Commission (Ireland)
Date15 July 2004
Submitted Date08 April 2008
Decision Date15 July 2004
Decision NumberM/04/020
15th July 2004
The Competition Authority clears UniPhar’s acquisition of
Whelehan Group
The Competition Authority announced today (15th July) that it w ill allow the
proposed acquisition by UniPhar plc (the parent company of the UniPhar Group)
of Ammado Limited, (the holding company for the Whelehan Group). Both
parties are involved in the wholesale distribution of pharmaceutical and
healthcare products.
The Competition Authority received notification of the proposed acquisition on
8th April 2004. The Authority has determined under the Mergers and
Acquisitions section of the Competition Act 2002 that the transaction will not
result in a “substantial lessening of competition” in any market for goods or
services in the State, and accordingly may be put into effect.
The Authority decided to carry out a full (Phase 2) investigation on 5th May
2004, having completed its initial (Phase 1) investigation. The Phase 2
investigation examined the competitive effect of the proposed acquisition on
the wholesale distribution of pharmaceutical and healthcare products to retail
For further information contact:
Mark Garrett, Communications Manager, The Competition Authority
Tel: 01 8045406 Mobile: 086 601 9655 email:
The Parties involved in the transaction:
UniPhar plc is a pharmaceutical wholesaling company and the parent company
of the UniPhar Group. A number of Irish retail pharmacists own UniPhar plc.
The UniPhar Group has three main business divisions, all of which are active in
the wholesaling of pharmaceutical products and also in the distribution of
healthcare products in Ireland. The divisions are: UniPhar plc, a wholesaler of
human pharmaceutical products to pharmacies throughout the State; Allphar
Services Limited, an agent and distributor of specialist hospital medicines,
diagnostic agents and ethical pharmaceuticals, for many international
pharmaceutical manufacturers; and Surgicare Limited, a distributor of surgical
and other healthcare products to hospitals. UniPhar also operates the
Independent Pharmacy Ownership Scheme (IPOS), which was established in
2001 to provide financial assistance to pharmacists who wish to purchase their
own pharmacies.
Page 1 of 2

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT